FDA Inspection 1304370 — Curexa - East, LLC
The FDA completed an inspection of Curexa - East, LLC on Mar 5, 2026 in Egg Harbor Township, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Egg Harbor Township, NJ (United States)